| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/02/1997 | CA2250183A1 Psa positive regulating (psar) sequences and uses thereof |
| 10/02/1997 | CA2250173A1 Cytochrome p450 transducing retroviral vectors |
| 10/02/1997 | CA2250099A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 10/02/1997 | CA2250058A1 Recombinant pox virus encoding myelin protein for therapy |
| 10/02/1997 | CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 10/02/1997 | CA2249254A1 Epidermal differentiation factor |
| 10/02/1997 | CA2248318A1 Growth factor htter36 |
| 10/01/1997 | EP0797680A1 Methods, compositions and apparatus for cell transfection |
| 10/01/1997 | EP0797679A2 Recombinant alphavirus vectors |
| 10/01/1997 | EP0797678A2 Hybrid adenovirus-aav virus and method of use thereof |
| 10/01/1997 | EP0797677A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 10/01/1997 | EP0797676A2 Recombinant adenoviral vector and methods of use |
| 10/01/1997 | EP0797663A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 10/01/1997 | EP0797581A1 Novel protein tyrosine kinase, jak3 |
| 10/01/1997 | EP0797455A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
| 10/01/1997 | EP0797454A1 Improved adenoviral vectors and producer cells |
| 10/01/1997 | EP0797446A1 Cd40 associated proteins |
| 10/01/1997 | EP0797436A1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| 10/01/1997 | EP0722331A4 Method for producing a highly enriched population of hematopoietic stem cells |
| 10/01/1997 | EP0648264A4 Bandage for continuous application of biologicals. |
| 09/30/1997 | US5672695 Modified ribozymes |
| 09/30/1997 | US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins |
| 09/30/1997 | US5672500 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 09/30/1997 | US5672344 Viral-mediated gene transfer system |
| 09/25/1997 | WO1997035200A1 Super-paramagnetic particles with increased r1 relaxivity, processes for producing said particles and use thereof |
| 09/25/1997 | WO1997035028A1 Cytostatin iii |
| 09/25/1997 | WO1997035027A1 Chemokine alpha 3 |
| 09/25/1997 | WO1997035024A1 Enzyme combinations for destroying proliferative cells |
| 09/25/1997 | WO1997035018A1 Growth factor inducible serine/threonine phosphatase fin13 |
| 09/25/1997 | WO1997035015A2 Tyrosine-phosphatase-related protein |
| 09/25/1997 | WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a) |
| 09/25/1997 | WO1997035012A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | WO1997035006A1 Human cell death-associated protein |
| 09/25/1997 | WO1997035005A2 Cftr gene regulator |
| 09/25/1997 | WO1997035004A1 Cell stimulation |
| 09/25/1997 | WO1997035003A1 Selective expression of desired genes in cells expressing oncoproteins |
| 09/25/1997 | WO1997035002A1 Purification of pharmaceutical-grade plasmid dna |
| 09/25/1997 | WO1997034998A1 Human cytokine polypeptide |
| 09/25/1997 | WO1997034997A1 Human endometrial specific steroid-binding factor i, ii and iii |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034639A1 Animal model for transplantation |
| 09/25/1997 | WO1997034638A1 Antisense approach to gene inhibition |
| 09/25/1997 | WO1997034624A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997034613A1 Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 09/25/1997 | WO1997034483A1 Methods for increasing or decreasing transfection efficiency |
| 09/25/1997 | WO1997022363A3 Improved pharmaceutical compositions |
| 09/25/1997 | DE19612001A1 Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung Superparamagnetic particles with increased relaxivity R¶1¶, methods of preparation and use thereof |
| 09/25/1997 | CA2250222A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249995A1 Chemokine alpha 3 |
| 09/25/1997 | CA2249585A1 Animal model for transplantation |
| 09/25/1997 | CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha. |
| 09/25/1997 | CA2249465A1 Purification of pharmaceutical-grade plasmid dna |
| 09/25/1997 | CA2249251A1 Human cytokine polypeptide |
| 09/25/1997 | CA2249196A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | CA2249179A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | CA2248868A1 Apoptosis inducing molecule ii |
| 09/25/1997 | CA2248629A1 Enzymes combinations for destroying proliferative cells |
| 09/25/1997 | CA2248614A1 Human cell death-associated protein |
| 09/25/1997 | CA2248136A1 Human endometrial specific steroid-binding factor i, ii and iii |
| 09/24/1997 | EP0796917A2 Vehicle for delivery of particles to a sample |
| 09/24/1997 | EP0796913A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins |
| 09/24/1997 | EP0796341A2 Identification of genes |
| 09/24/1997 | EP0796339A1 Packaging cell lines for generation of high titers of recombinant aav vectors |
| 09/24/1997 | EP0796338A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 09/24/1997 | EP0796331A2 Production and administration of high titer recombinant retroviruses |
| 09/24/1997 | EP0796325A1 Human vascular ibp-like growth factor |
| 09/24/1997 | EP0796320A1 Human dna ligase iii |
| 09/24/1997 | EP0796280A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/24/1997 | EP0796276A1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 09/24/1997 | EP0796275A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 09/24/1997 | EP0796274A2 Chromosome 21 gene marker, compositions and methods using same |
| 09/24/1997 | EP0796240A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 09/24/1997 | EP0796110A2 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
| 09/24/1997 | EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 09/24/1997 | EP0796104A1 Delivery of nucleic acid molecules to mucosal tissue |
| 09/23/1997 | US5670634 Inhibit expression of peptide of alzheimer's disease and down's syndrome |
| 09/23/1997 | US5670633 Sugar modified oligonucleotides that detect and modulate gene expression |
| 09/23/1997 | US5670488 Adenovirus vector for gene therapy |
| 09/23/1997 | US5670367 Recombinant fowlpox virus |
| 09/23/1997 | US5670361 HIV-specific ribozymes |
| 09/23/1997 | US5670354 Use of VSV-G pseudotyped vectors for transfer of genes into embryos |
| 09/23/1997 | US5670351 Methods and compositions for the ex vivo replication of human hematopoietic stem cells |
| 09/23/1997 | US5670147 Compositions containing cultured mitotic human stem cells |
| 09/18/1997 | WO1997034009A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033993A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | WO1997033991A1 Short external guide sequences |
| 09/18/1997 | WO1997033990A1 Regulatory element for interleukin-5 |
| 09/18/1997 | WO1997033986A1 Arginase ii |
| 09/18/1997 | WO1997033985A1 Arginase ii |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |